Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Clinical trial NCT03375320 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03375320
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Functioning Pancreatic Neuroendocrine Tumor Intermediate Grade Lung Neuroendocrine Neoplasm Locally Advanced Digestive System Neuroendocrine Neoplasm Locally Advanced Digestive System Neuroendocrine Tumor G1 Locally Advanced Lung Neuroendocrine Neoplasm Locally Advanced Pancreatic Neuroendocrine Tumor Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm Low Grade Lung Neuroendocrine Neoplasm Lung Neuroendocrine Tumor Lung Neuroendocrine Tumor G2 Metastatic Digestive System Neuroendocrine Neoplasm Metastatic Digestive System Neuroendocrine Tumor G1

Start date: 2018-10-26
Primary completion: 2023-08-23
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.